Rapid Respiratory Infection Panel

The Rapid Respiratory Infection Panel is a rapid antigen test used to detect selected viruses that commonly cause acute respiratory infections. A swab sample is tested for respiratory syncytial virus (RSV), influenza A, influenza B, adenovirus, and SARS-CoV-2. Results are typically available in approximately 30 minutes.

The panel can help clarify whether one of the included viruses may be responsible for current symptoms. It does not provide a complete diagnosis, assess disease severity, or identify every possible respiratory pathogen. The result should be considered together with symptom onset, recent exposure, age, health risks, and clinical findings.

When the panel may be considered

Testing may be useful after the recent onset of fever, sore throat, chills, nasal symptoms, muscle aches, or coughing, wheezing, and shortness of breath. Viral infections may also cause fatigue and low energy, reduced appetite, headache, and a general feeling of illness.

Sneezing, a runny nose, and a blocked nose can occur with both a viral infection and an allergy. An allergy is more likely when symptoms repeatedly follow exposure to pollen, dust, animals, or another trigger and are accompanied by itching of the eyes, nose, or throat. Viral illness more often has an acute onset and may include fever, sore throat, chills, muscle aches, or recent contact with an infected person. These patterns can guide evaluation, but they cannot confirm the cause without appropriate assessment.

The respiratory panel tests for viruses and does not diagnose allergic rhinitis or asthma. When symptoms are predominantly seasonal, exposure-related, or associated with itchy and watery eyes without signs of an acute infection, an allergy assessment may be more informative.

What the panel detects

• Respiratory syncytial virus: RSV can cause upper or lower respiratory infection and may be more clinically significant in infants, older adults, and people with certain heart, lung, or immune conditions.
• Influenza A and B: influenza often begins suddenly and may cause fever, chills, muscle aches, headache, marked fatigue, sore throat, and cough.
• Adenovirus: adenovirus may cause respiratory symptoms and can also be associated with eye irritation, fever, or gastrointestinal symptoms.
• SARS-CoV-2: the virus responsible for COVID-19 may cause a wide range of respiratory and systemic symptoms.

The test does not detect respiratory viruses that are not included in the panel. It also does not identify bacterial infections such as streptococcal throat infection or bacterial pneumonia. A person can therefore have an infectious respiratory illness even when all panel targets are negative.

Why sampling time matters

Rapid antigen tests detect viral proteins in the collected sample. Their ability to identify an infection depends partly on how much viral material is present at the time of sampling. Testing during the acute symptomatic phase often provides the most useful result, but the optimal period can vary according to the virus, the test, and the individual course of infection.

A sample taken very early, before the amount of detectable antigen has increased, may produce a negative result despite infection. Detection may also become less likely later in the illness as the amount of virus declines. Inadequate sample collection, handling, or testing technique can further reduce sensitivity.

For these reasons, a negative rapid result does not completely exclude infection. When symptoms remain strongly suggestive, worsen, or occur after a significant exposure, repeat testing, a more sensitive molecular test such as PCR, or clinical evaluation may be appropriate.

How the test is performed

Step 1: Review of symptoms and timing

Before sampling, it is useful to establish when the symptoms began, whether they are worsening or improving, whether there was known exposure, and whether another respiratory test has already been performed. This information helps determine whether a rapid panel is an appropriate first test.

Step 2: Swab collection

A respiratory swab is collected according to the test protocol. Collection is brief but may cause temporary pressure, irritation, watering of the eyes, sneezing, or an urge to cough.

Step 3: Rapid antigen analysis

The sample is analyzed for the selected viral antigens. No blood sample, anesthesia, or recovery period is involved.

Step 4: Report

The report is generally available in approximately 30 minutes and indicates whether the included viral targets were detected or not detected.

Step 5: Interpretation and next step

The result is interpreted alongside the clinical picture. A detected target may help direct further advice and monitoring. A negative result may be sufficient in some situations, while persistent or concerning symptoms may require repeat testing, PCR or another molecular test, examination, or additional diagnostics.

How to understand the result

A detected result means that antigen from the stated virus was found in the collected sample. It does not by itself determine how severe the illness will be, whether complications will occur, or how long symptoms will last.

A not-detected result means that the test did not identify the included viral antigen in that particular sample. It does not prove that the person has no respiratory infection, is not contagious, or has an allergy instead. The cause may be a virus outside the panel, a bacterial infection, a noninfectious respiratory condition, or an included virus that was not present in a detectable amount.

Who may benefit and when another pathway is needed

The panel may be considered for people with recent acute respiratory symptoms, suspected exposure, or uncertainty about which of the included viruses may be involved. Testing can also be useful when a rapid result may help determine whether additional medical assessment or molecular confirmation is needed.

A rapid panel is not a substitute for examination when breathing is difficult, symptoms are severe, the person belongs to a medically vulnerable group, or complications are suspected. Persistent cough, recurrent wheezing, prolonged nasal symptoms, or symptoms consistently linked to allergens may require pulmonary, allergy, ear, nose and throat, or other clinical evaluation rather than repeated infection testing alone.

Key facts

• Test type: rapid respiratory antigen panel
• Sample: respiratory swab
• Targets: RSV, influenza A, influenza B, adenovirus, and SARS-CoV-2
• Result time: approximately 30 minutes
• Main limitation: a negative result does not fully exclude infection
• Not assessed: allergy, disease severity, bacterial causes, and viruses outside the panel

When not to wait for a test result

Urgent medical assessment is more important than routine testing when there is severe or rapidly worsening shortness of breath, inability to speak in full sentences, blue or gray lips, significant chest pain, confusion, loss of consciousness, signs of severe dehydration, or marked deterioration in a child, older adult, or medically vulnerable person.

What to prepare before sending an inquiry

Prepare the date and approximate time when symptoms started, the main symptoms, recent fever, known exposure, previous respiratory test results, current medications, and relevant heart, lung, immune, or other chronic conditions. It is also useful to mention whether symptoms are acute or follow a seasonal or exposure-related pattern.

You can send ZagrebMed a short description of the symptoms and their duration, together with any existing test results. ZagrebMed can help clarify whether the rapid panel fits the current situation or whether clinical assessment or another diagnostic test may be a more appropriate next step.